# Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment

> **NCT02336399** · — · UNKNOWN · sponsor: **Beijing Ditan Hospital** · enrollment: 420 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02336399
- **Lead sponsor:** Beijing Ditan Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-09
- **Primary completion:** 2016-12
- **Final completion:** 2021-12
- **Target enrollment:** 420 (ACTUAL)
- **Last updated:** 2017-11-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02336399

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02336399, "Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT02336399. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*